K2 HealthVentures Equity Trust LLC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:41 pm Purchase | 2022-10-25 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP | K2 HealthVentures Equity Trust LLC | 10,524,401 7.800% | 10,524,401 (New Position) | Filing |